22. Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Summary of consolidated stock-based compensation expense, by type of awards

The following table summarizes the consolidated share-based compensation expense from continuing operations, by type of awards:

	For the Years Ended
	December 31,		December 31,		December 31,
	2019		2018		2017
Employee stock options	$	305	$	1,799	$	886
Restricted stock grants		516		927		288
Total share-based compensation expense	$	821	$	2,726	$	1,174

Summary of consolidated stock-based compensation by line items

The following table summarizes the consolidated share-based compensation by line items from continuing operations:

	For the Years Ended
	December 31, 2019		December 31, 2018		December 31, 2017
General and administrative	$	768	$	2,579	$	1,131
Sales, marketing and customer service		53		147		43
Total share-based compensation expense	$	821	$	2,726	$	1,174

Summary of assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants

Assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants were as follows:

	For the Years Ended
	December 31, 2019		December 31, 2018		December 31, 2017
Expected term		6.25		6.25		6.25
Risk-free interest rate		1.55%-2.51%		2.54%-3.03%		1.81%-2.30%
Expected volatility		575%-605%		624%-756%		284%-763%
Expected dividend yield		0%		0%		0%

Summary of stock option activities

	Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2016		550,760			82		7.40	$	60,032
Granted		325,300			4
Exercised		–			–
Forfeited/expired		(374,800	)		36
Outstanding as of December 31, 2017		501,260			66		7.03	$	769
Granted		287,000			13
Exercised		–			–
Forfeited/expired		(528,060	)		10
Outstanding as of December 31, 2018		260,200			212		8.59	$	–
Granted		65,000			3
Exercised		–			–
Forfeited/expired		(70,000	)		4
Outstanding as of December 31, 2019		255,200			19		6.70	$	–
Vested and exercisable as of December 31, 2019		139,450			24		6.47	$	–
Expected to vest as of December 31, 2019		124,355			26		6.45	$	–

Summary of exercise price and remaining life information about options exercisable

Range of exercise price	Shares Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Aggregate Intrinsic ($000)
$118 - $172		1,000		5.13	$	172.00	$	–
$40 - $117		42,300		6.38	$	63.61		–
$2 - $39		93,650		7.33	$	5.60		–
$1-$2		2,5000		9.69	$	1.96		–
		139,450					$	–

Summary of restricted stock awards

	Number of Shares			Weighted Average Grant-Date Fair Value
Restricted stock units at December 31, 2016		217,059		$	151
Granted		–			–
Forfeited		(1,250	)		177
Restricted stock units at December 31, 2017		215,809			151
Granted		663,460			1
Forfeited		(250	)		185
Restricted stock units at December 31, 2018		879,019			38
Granted		107,000			3
Forfeited		-			-
Restricted stock units at December 31, 2019		986,019		$	34

Summary of changes in non-vested stock awards

	Time-based Options					Restricted Stock
	Shares			Weighted Average Exercise Price Per Share		Shares			Weighted Average Grant-Date Fair Value Per Share
Non-vested as of December 31, 2016		430,358		$	46		4,750		$	178
Granted		325,300			4		–			–
Vested		(100,663	)		43		(2,187	)		128
Forfeited		(275,075	)		48		(1,250	)		177
Non-vested as of December 31, 2017		379,920		$	9		1,313		$	264
Granted		287,000			13		663,460			1
Vested		(87,285	)		25		(663,273	)		1
Forfeited		(396,335	)		13		(250	)		185
Non-vested as of December 31, 2018		183,300		$	8		1,250		$	185
Granted		65,000			3		107,000			3
Vested		(70,050	)		17		(108,250	)		5
Forfeited		(62,500	)		4		–			–
Non-vested as of December 31, 2019		115,750		$	11		–		$	–